Press Releases
Ferrer successfully completes a phase III clinical trial in adult and paediatric patients with impetigo for novel antibacterial compound Ozenoxacin
Ferrer, a privately-held Spanish pharmaceutical company with full vertical integration from R&D to distribution, announces today that it has successfully completed a phase III clinical...
Press Releases
Biogen Idec 2013 Annual Shareholder Meeting Webcast
Biogen Idec Inc. announced today that its 2013 Annual Shareholder Meeting will be webcast live on Wednesday June 12 2013 at 9:00 a.m. ET. To...
Press Releases
Novasep appoints Udo Steinhauer as fine chemicals market director, strengthening its fine chemical business
Novasep, a leading supplier of manufacturing solutions to the life sciences industry, announces it has strengthened its position in the fine chemicals marketplace with the...
Press Releases
Strong foundation for a thriving ‘Medical Tourism’ industry in UAE
The UAE is currently witnessing progress in the global medical tourism industry today. Being a melting pot of cultures and located only a few...
Press Releases
Almac secures new metagenomics and enzyme discovery
The BBRSC Programme combines Chemistry and Biochemical Engineering at UCL with Almac’s Biocatalysis Group. The Almac biocatalysis group has secured...
Press Releases
Curie-Cancer and Roche strengthen partnership to fast-track the development of new molecules
Curie-Cancer, the body responsible for developing Institut Curie’s industry partnership activities, and the Roche Institute for Research and Translational Medicine are strengthening their collaborative efforts....
Press Releases
Abbott Announces CE Mark for Test to Aid Doctors with Diagnosing and Monitoring Diabetes
Abbott today announced CE Marking (Conformité Européenne) for the ARCHITECT clinical chemistry Hemoglobin A1c (HbA1c) test, which may aid physicians in diagnosing and monitoring...
Subscribe
- Never miss a story with notifications
- Gain full access to our premium content
- Browse free from any location or device.